Graft-Versus-Leukemia Effect Is Independent from Graft-Versus-Host Disease Following Ptcy-Based HLA-Haploidentical Transplantation

被引：0

作者：

Baron, Frederic ^{[1
,2
]}

Labopin, Myriam ^{[3
]}

Tischer, Johanna ^{[4
]}

Raiola, Anna Maria ^{[5
]}

Vydra, Jan ^{[6
]}

Blaise, Didier ^{[7
]}

Chiusolo, Patrizia ^{[8
]}

Stoelzel, Friedrich ^{[9
]}

Fanin, Renato ^{[10
]}

Chevallier, Patrice ^{[11
]}

Nagler, Arnon ^{[12
]}

Ciceri, Fabio ^{[13
]}

Mohty, Mohamad ^{[14
,15
,16
]}

机构：

[1] CHU Sart Tilman, Dept Hematol, Liege, Belgium

[2] Univ Liege, Liege, Belgium

[3] Sorbonne Univ, St Antoine Hosp, AP HP, EBMT Stat Unit,INSERM UMRs 938, Paris, France

[4] Univ Hosp Munich, Dept Internal Med 3, Campus Grosshadern, Munich, Germany

[5] IRCCS, Div Ematol, Policlin San Martino, Genoa, Italy

[6] Inst Hematol & Blood Transfus, Prague, Czech Republic

[7] Inst Paoli Calmettes, Hematol Dept, Marseille, France

[8] IRCCS, Dept Diagnost Immagini Radioterapia Oncol Ematol, Fdn Policlin Univ A Gemelli, Rome, Italy

[9] Tech Univ Dresden, Univ Hosp, Dresden, Germany

[10] Udine Univ Hosp, Div Hematol, Udine, Italy

[11] Nantes Univ Hosp, Hematol Dept, Nantes, France

[12] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel

[13] Univ Vita Salute San Raffaele, IRCCS, Unit Hematol & Bone Marrow Transplantat, San Raffaele Sci Inst, Milan, Italy

[14] CEREST TC, EBMT Paris Study Off, Paris, France

[15] St Antoine Hosp, Dept Hematol, Paris, France

[16] Sorbonne Univ, INSERM UMR 938, Paris, France

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-166023

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：7752 / 7753

页数：2

共 50 条

[1] GRAFT-VERSUS-LEUKEMIA EFFECT OF GRAFT-VERSUS-HOST DISEASE
CLINK, HM
[J]. LANCET, 1987, 1 (8526): : 219 - 219
[2] Graft-versus-host disease and graft-versus-leukemia
Michallet, M
[J]. HEMATOLOGY AND CELL THERAPY, 1996, 38 (05): : 459 - 460
[3] Graft-versus-host disease versus graft-versus-leukemia
Negrin, Robert S.
[J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 225 - 230
[4] Effect of deoxyspergualin on graft-versus-host disease and graft-versus-leukemia in mice
Weiss, L
Reich, S
Slavin, S
[J]. BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 789 - 792
[5] Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect
Alyea, Edwin P.
[J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) : 239 - 250
[6] Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation
Shimon Slavin
[J]. International Journal of Hematology, 2003, 78 : 195 - 207
[7] Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation
Slavin, S
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (03) : 195 - 207
[8] Cytokines in Graft-Versus-Host Disease and the Graft-Versus-Leukemia Reaction
H. Joachim Deeg
[J]. International Journal of Hematology, 2001, 74 : 26 - 32
[9] Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction
Deeg, HJ
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 74 (01) : 26 - 32
[10] T-CELL DEPLETION OF HLA AND HAPLOIDENTICAL MARROW REDUCES GRAFT-VERSUS-HOST DISEASE BUT IT MAY IMPAIR A GRAFT-VERSUS-LEUKEMIA EFFECT
HENSLEE, PJ
THOMPSON, JS
ROMOND, EH
DOUKAS, MA
METCALFE, M
MARSHALL, ME
MACDONALD, JS
[J]. TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 2701 - 2706

← 1 2 3 4 5 →